Alzain (pregabalin): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Medication indications

Alzain 100 mg Capsules, Hard

Neuropathic pain

Alzain is indicated for the treatment of peripheral and central neuropathic pain in adults.

Epilepsy

Alzain is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Generalised Anxiety Disorder

Alzain is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Alzain 150 mg Capsules, Hard

Neuropathic pain

Alzain is indicated for the treatment of peripheral and central neuropathic pain in adults.

Epilepsy

Alzain is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Generalised Anxiety Disorder

Alzain is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Alzain 200 mg Capsules, Hard

Neuropathic pain

Alzain is indicated for the treatment of peripheral and central neuropathic pain in adults.

Epilepsy

Alzain is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Generalised Anxiety Disorder

Alzain is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Alzain 225 mg Capsules, Hard

Neuropathic pain

Alzain is indicated for the treatment of peripheral and central neuropathic pain in adults.

Epilepsy

Alzain is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Generalised Anxiety Disorder

Alzain is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Alzain 25 mg Capsules, Hard

Neuropathic pain

Alzain is indicated for the treatment of peripheral and central neuropathic pain in adults.

Epilepsy

Alzain is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Generalised Anxiety Disorder

Alzain is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Alzain 300 mg Capsules, Hard

Neuropathic pain

Alzain is indicated for the treatment of peripheral and central neuropathic pain in adults.

Epilepsy

Alzain is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Generalised Anxiety Disorder

Alzain is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Alzain 50 mg Capsules, Hard

Neuropathic pain

Alzain is indicated for the treatment of peripheral and central neuropathic pain in adults.

Epilepsy

Alzain is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Generalised Anxiety Disorder

Alzain is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Alzain 75 mg Capsules, Hard

Neuropathic pain

Alzain is indicated for the treatment of peripheral and central neuropathic pain in adults.

Epilepsy

Alzain is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Generalised Anxiety Disorder

Alzain is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.


Route of administration: Oral
Molecule: pregabalin

Patients' opinions on Alzain

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.

Conditions related to this medication

Fact sheet

Epilepsy

See the fact sheet